BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8674670)

  • 1. Intervention in the complement system: a therapeutic strategy in inflammation.
    Morgan BP
    Biochem Soc Trans; 1996 Feb; 24(1):224-9. PubMed ID: 8674670
    [No Abstract]   [Full Text] [Related]  

  • 2. Human complement regulatory proteins in transgenic animals regulate complement activation in xenoperfused organs.
    McCurry KR; Kooyman DL; Diamond LE; Byrne GW; Martin MJ; Logan JS; Platt JL
    Transplant Proc; 1995 Feb; 27(1):317-8. PubMed ID: 7533396
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacological effects on the complement system. Possibilities and limitations of anti-inflammatory therapy].
    Kirschfink M
    Dtsch Med Wochenschr; 1995 Aug; 120(31-32):1087-90. PubMed ID: 7641591
    [No Abstract]   [Full Text] [Related]  

  • 4. Human complement regulatory proteins expressed in transgenic swine protect swine xenografts from humoral injury.
    McCurry KR; Diamond LE; Kooyman DL; Byrne GW; Martin MJ; Logan JS; Platt JL
    Transplant Proc; 1996 Apr; 28(2):758. PubMed ID: 8623384
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting complement in therapy.
    Kirschfink M
    Immunol Rev; 2001 Apr; 180():177-89. PubMed ID: 11414360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement in human diseases: looking towards the 21st century.
    Pascual M; French LE
    Immunol Today; 1995 Feb; 16(2):58-61. PubMed ID: 7888067
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on transfer of primate membrane-associated complement inhibitors from recipient blood to porcine donor organs.
    Kroshus TJ; Bolman RM; Dalmasso AP
    Transplant Proc; 1996 Apr; 28(2):601-2. PubMed ID: 8623295
    [No Abstract]   [Full Text] [Related]  

  • 8. [Complement in organ xenotransplantation].
    Dalmasso AP
    Rev Clin Esp; 1996 Mar; 196 Spec No():44-51. PubMed ID: 9206808
    [No Abstract]   [Full Text] [Related]  

  • 9. Complement regulatory molecules: application to therapy and transplantation.
    Morgan BP
    Immunol Today; 1995 Jun; 16(6):257-9. PubMed ID: 7544975
    [No Abstract]   [Full Text] [Related]  

  • 10. Are pigs transgenic for human complement regulatory proteins necessary for xenotransplantation?
    Loveland BE; Cooper DK; Sandrin MS
    Transplantation; 2000 Aug; 70(4):567-8. PubMed ID: 10972209
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro and in vivo studies to prevent hyperacute rejection.
    Miyagawa S; Mikata M; Matsuda H; Ikawa M; Okabe M; Nagasawa S; Matsumoto M; Seya T; Shirakura R
    Transplant Proc; 1996 Apr; 28(2):1031-3. PubMed ID: 8623217
    [No Abstract]   [Full Text] [Related]  

  • 12. Endothelial expression of human decay accelerating factor in transgenic pig tissue: a potential approach for human complement inactivation in discordant xenografts.
    Rosengard AM; Cary N; Horsley J; Belcher C; Langford G; Cozzi E; Wallwork J; White DJ
    Transplant Proc; 1995 Feb; 27(1):326-7. PubMed ID: 7533400
    [No Abstract]   [Full Text] [Related]  

  • 13. Reactions and side reactions to drugs.
    Rother U
    Prog Allergy; 1986; 39():123-33. PubMed ID: 3562461
    [No Abstract]   [Full Text] [Related]  

  • 14. Development and analysis of transgenic pigs expressing the human complement regulatory protein CD59 and DAF.
    Byrne G; McCurry K; Martin M; Platt J; Logan J
    Transplant Proc; 1996 Apr; 28(2):759. PubMed ID: 8623385
    [No Abstract]   [Full Text] [Related]  

  • 15. Inactivation of C3 and C5 prolongs cardiac xenograft survival and decreases leukocyte infiltration in a model of delayed xenograft rejection.
    Johnson EM; Leventhal J; Dalmasso AP; Goswitz J; Simone P; Chen S; Matas AJ
    Transplant Proc; 1996 Apr; 28(2):603. PubMed ID: 8623296
    [No Abstract]   [Full Text] [Related]  

  • 16. Animal models for complement deficiencies.
    Frank MM
    J Clin Immunol; 1995 Nov; 15(6 Suppl):113S-121S. PubMed ID: 8613484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged survival of guinea pig hearts in rats after combined antibody and complement depletion.
    Scheringa M; Blanker R; Bemelman M; Schraa E; de Bruin R; Bouwman E; IJzermans J; Marquet R
    Transplant Proc; 1995 Feb; 27(1):303-4. PubMed ID: 7879011
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of complement-mediated liver damage and protection in control and transgenic mice for human complement blockers MCP and DAF.
    Mulder LC; Mora M; Lazzeri M; Boschi M; Ciccopiedi E; Marinucci G; Melli CM; Bruzzone P; Alfani D; Cortesini R; Rossini M
    Transplant Proc; 1996 Feb; 28(1):127-9. PubMed ID: 8644143
    [No Abstract]   [Full Text] [Related]  

  • 19. [Xenotransplantation].
    White DJ; Calne RY
    Chirurg; 1996 Apr; 67(4):324-30. PubMed ID: 8646917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement depletion prolongs discordant cardiac xenograft survival in rodents and non-human primates.
    Leventhal JR; Dalmasso AP; Cromwell JW; Manivel CJ; Bolman RM; Matas AJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):398-9. PubMed ID: 8438352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.